177 related articles for article (PubMed ID: 35320951)
21. Interleukin-1 receptor-associated kinase 1 correlates with metastasis and invasion in endometrial carcinoma.
Wang Y; Wang Y; Duan X; Wang Y; Zhang Z
J Cell Biochem; 2018 Mar; 119(3):2545-2555. PubMed ID: 28980703
[TBL] [Abstract][Full Text] [Related]
22. RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma.
Liu S; Lin M; Ji H; Ding J; Zhu J; Ma R; Meng F
Diagn Pathol; 2019 Jan; 14(1):7. PubMed ID: 30684972
[TBL] [Abstract][Full Text] [Related]
23. Prognostic and clinicopathological significance of TMEFF2, SMOC-2, and SOX17 expression in endometrial carcinoma.
Alabiad MA; Harb OA; Hefzi N; Ahmed RZ; Osman G; Shalaby AM; Alnemr AA; Saraya YS
Exp Mol Pathol; 2021 Oct; 122():104670. PubMed ID: 34339705
[TBL] [Abstract][Full Text] [Related]
24. Markers of the epithelial-mesenchymal transition in cells of endometrial carcinoma.
Nesina IP; Iurchenko NP; Buchynska LG
Exp Oncol; 2018 Oct; 40(3):218-222. PubMed ID: 30284998
[TBL] [Abstract][Full Text] [Related]
25. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
Wu H; Zhang J
Gynecol Oncol; 2018 Jun; 149(3):592-597. PubMed ID: 29602546
[TBL] [Abstract][Full Text] [Related]
26. Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer.
Jorge S; Hou JY; Tergas AI; Burke WM; Huang Y; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2016 Mar; 140(3):387-93. PubMed ID: 26768835
[TBL] [Abstract][Full Text] [Related]
27. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
[No Abstract] [Full Text] [Related]
28. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
[TBL] [Abstract][Full Text] [Related]
29. The relationship between mutant p53 gene, DNA contents and conventional clinicopathological prognostic variables in cases with endometrial carcinoma.
Osmanağaoğlu MA; Kadioğlu S; Osmanağaoğlu S; Bozkaya H; Reis A; Tekelioğlu Y
Eur J Gynaecol Oncol; 2005; 26(1):64-70. PubMed ID: 15755004
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-21 expression in cancer cells is an independent biomarker of progression-free survival of endometrioid endometrial carcinoma.
Sato K; Miyamoto M; Takano M; Tsuda H
Virchows Arch; 2021 Nov; 479(5):883-891. PubMed ID: 34331128
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of HPIP as a biomarker for metastasis and prognosis prediction in endometrial cancer patients.
Cheng L; Zhao T; Li S; Wang Y; Fei H; Meng F
J Clin Lab Anal; 2019 Oct; 33(8):e22959. PubMed ID: 31241209
[TBL] [Abstract][Full Text] [Related]
32. Expression levels of hnRNP G and hTra2-beta1 correlate with opposite outcomes in endometrial cancer biology.
Ouyang YQ; zur Hausen A; Orlowska-Volk M; Jäger M; Bettendorf H; Hirschfeld M; Tong XW; Stickeler E
Int J Cancer; 2011 May; 128(9):2010-9. PubMed ID: 20607830
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression of UBE2C in endometrial cancer and its correlation to epithelial mesenchymal transition.
Zhang Y; Li X; Gong Y; Du D; Chen H; Liu L; Cheng Z
Medicine (Baltimore); 2023 May; 102(20):e33834. PubMed ID: 37335710
[TBL] [Abstract][Full Text] [Related]
34. Correlation of TNFAIP8 overexpression with the proliferation, metastasis, and disease-free survival in endometrial cancer.
Liu T; Gao H; Yang M; Zhao T; Liu Y; Lou G
Tumour Biol; 2014 Jun; 35(6):5805-14. PubMed ID: 24590269
[TBL] [Abstract][Full Text] [Related]
35. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
He Z; Xu H; Meng Y; Kuang Y
Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of ESPL1 is associated with poor prognostic outcomes in endometrial cancer.
Yang Y; Sheng Y; Zheng J; Ma A; Chen S; Lin J; Yang X; Liang Y; Zhang Y; Zheng X
Biomarkers; 2024 Jun; 29(4):185-193. PubMed ID: 38568742
[TBL] [Abstract][Full Text] [Related]
37. Identification of a novel subgroup of endometrial cancer patients with loss of thyroid hormone receptor beta expression and improved survival.
Piqué DG; Greally JM; Mar JC
BMC Cancer; 2020 Sep; 20(1):857. PubMed ID: 32894083
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of connective tissue growth factor is associated with tumor progression and unfavorable prognosis in endometrial cancer.
Li XT; Li JY; Zeng GC; Lu L; Jarrett MJ; Zhao Y; Yao QZ; Chen X; Yu KJ
Cancer Biomark; 2019; 25(4):295-302. PubMed ID: 31306107
[TBL] [Abstract][Full Text] [Related]
39. Aberrant TRPC1 expression reflects stromal cervical invasion, lymphovascular invasion, elevated FIGO stage, and poor survival in resectable endometrial carcinoma patients.
Wang Y; Zhang C
J Clin Lab Anal; 2022 Aug; 36(8):e24560. PubMed ID: 35754147
[TBL] [Abstract][Full Text] [Related]
40. Isolated tumor cells and micrometastases in regional lymph nodes in stage I to II endometrial cancer.
Todo Y; Kato H; Okamoto K; Minobe S; Yamashiro K; Sakuragi N
J Gynecol Oncol; 2016 Jan; 27(1):e1. PubMed ID: 25925293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]